| dc.description.abstract | The Drugs for Neglected Diseases Initiative (DNDi) is a not-for-profit
organisation with headquarters in Geneva, Switzerland. Founded by six research
institutions and an international humanitarian organisation*, DNDi addresses the
need for new field-adapted, effective, and affordable drugs for patients suffering
from neglected diseases. DNDi harnesses knowledge and cutting-edge science
and technology to research and develop critically needed drugs for neglected
diseases such as leishmaniasis, trypanosomiasis, and Chagas disease, ensuring
their suitability and accessibility to the poorer patients of the world. To achieve
this, DNDi works predominantly with developing country organizations and
governments. | en_US |
